bn:02908795n
Noun Named Entity
AR
No term available
EN
RO-4491533 is a drug developed by Hoffmann-La Roche which acts as a potent and selective negative allosteric modulator for group II of the metabotropic glutamate receptors, being equipotent at mGluR2 and mGluR3 but without activity at other mGluR subtypes. Wikipedia
Relations
Sources